AzTrials
AzTrials

Ischemic or Hemorrhagic StrokeART-CONNECTNCT03820843

Impact of Art Therapy on Brain Connectivity in Recent Post-Stroke Aphasia

A study testing Art therapy and standard orthophonic rehabilitation in people with Ischemic or Hemorrhagic Stroke, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A stroke located in the left parieto-temporal junction is associated, in aphasic right-handed patients, with a poor prognosis for language recovery. The role of the right hemisphere in recovering post-stroke aphasia is still controversial. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ischemic or Hemorrhagic Stroke
What is being tested?
Art therapy and standard orthophonic rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteFrance
Study dates
17 Feb 2020to 17 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with recent ischemic or haemorrhagic stroke with unilateral lesion (s) of the parieto-temporal left junction present on the Diffusion MRI (DWI) performed in acute phase at 24-48h
  • Post stroke delay of 15 days to 2 months
  • Existence of moderate to severe phasic disorders on Aphasia Rapid Test score (ART, score> 6, scale of 26 items)
  • Patient able to read and understand French
  • Rightful
  • Normal and corrected vision and hearing
Show all 9Show fewer
  • Absence of pre-existing degenerative neurological disorder
  • Patient having signed his consent
  • Age ≥ 18 years

Who cannot join

  • Patients with contraindications to MRI or claustrophobic
  • Patients under legal protection
  • Patients with behavioral disorders or disabling neurovisual disorders making participation in art therapy impossible
  • Mute patients, illiterate patients
  • Patients leaving the neurological SSR department prematurely
  • Patients not affiliated to a social security scheme
  • Pregnant or lactating women.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Groupe Hospitalier Pitié-Salpêtrière, Soins de Suite et Réadaptation

    Paris, 75013

Other trials in France

About this study

Official title: Impact of Art Therapy on Brain Connectivity in Recent Post-Stroke Aphasia (ART-CONNECT)

A stroke located in the left parieto-temporal junction is associated, in aphasic right-handed patients, with a poor prognosis for language recovery. The role of the right hemisphere in recovering post-stroke aphasia is still controversial. Our hypothesis, based on recent work in imaging, is that early activation of the right hemisphere linked to the practice of the visual arts could facilitate language recovery in extended posterior left strokes that completely disrupt language areas.

Read the detailed description

The investigators will evaluate, at inclusion and at 6 weeks, the reorganization of functional and structural brain connectivity maps before and after rehabilitation of aphasia with art therapy and standard orthophonic rehabilitation versus a control group that received only standard orthophonic rehabilitation.

The investigators will include all consecutive patients with recent ischemic or hemorrhagic stroke with unilateral lesion(s) of the parieto-temporal left junction present on the Diffusion MRI (DWI) performed in acute phase at 24-48h.

All patients will undergo 2 MRI with tensor diffusion sequences (structural connectivity) and fMRI (functional magnetic resonance imaging) resting state sequences (functional connectivity) at inclusion and 6 weeks after rehabilitation with or without art therapy.

The investigators aimed to demonstrate that early activation of the right hemisphere related to the practice of the visual arts could facilitate the recovery of language in later strokes completely disrupting the language areas of the left hemisphere.

Being tested
Art therapy and standard orthophonic rehabilitation
Keywords
brain connectivity, aphasia, art therapy, rehabilitation
Medical subject headings
Ischemia, Hemorrhagic Stroke, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Art therapy and standard orthophonic rehabilitationOther

    In addition to standard orthophonic rehabilitation, the patient will receive 12 sessions of art therapy

Study groups in NCT03820843
Study groupRoleWhat they receive
Art therapyExperimentalArt therapy and standard orthophonic rehabilitation
Receives: Other: Art therapy and standard orthophonic rehabilitation
Control groupNo interventionOnly standard orthophonic rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change from baseline measurement of white substance bundles volumes for structural connectivity at 6 weeks

    Measured: from inclusion at 6 weeks

  2. change from baseline measurement of synchrony amplitude of slow fluctuations for functional Connectivity at 6 weeks

    Measured: from inclusion at 6 weeks

Secondary outcomes (5)
  1. change from baseline Aphasia at 6 weeks

    The BDAE (Boston Diagnostic Aphasia Examination) score ranges from 0 to 5, with higher values indicating more severe impairment

    Measured: from inclusion at 6 weeks

  2. change from baseline Aphasia at 6 weeks

    The ART (Aphasia Rapid Test) score ranges from 0 to 26, with higher values indicating more severe impairment

    Measured: from inclusion at 6 weeks

  3. change from baseline Anxiety and depression at 6 weeks

    The HADS (Hospital Anxiety and Depression Scale) scores ranges from 0 to 21 for both anxiety and depression scores, with higher values indicating more severe impairment

    Measured: from inclusion and at 6 weeks

  4. change from baseline Quality of life self-assessment at 6 weeks

    Visual Analogic scale of patient quality of life is a 0% to 100% scale, with 100 indicating the best health status

    Measured: from inclusion at 6 weeks

  5. Satisfaction self-assessment at 6 weeks

    visual analogic scale of patient satisfaction is a 0 to 10 scale, with higher values indicating better satisfaction

    Measured: at 6 weeks only

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2019
  2. Study start17 Feb 2020
  3. Primary completion16 Dec 2024
  4. Study completion17 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The investigators will evaluate the reorganization of functional and structural brain connectivity maps before and after rehabilitation of aphasia with art therapy and standard orthophonic rehabilitation versus a control group that received only standard orthophonic rehabilitation.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03820843
Sponsor's protocol ID
APHP180312
Other IDs
N° IDRCB: 2018-A02462-53
Acronym
ART-CONNECT
Status last verified
Jan 2026
First submitted
10 Jan 2019
Last updated
23 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Art therapy and standard orthophonic rehabilitation in people with Ischemic or Hemorrhagic Stroke, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change from baseline measurement of white substance bundles volumes for structural connectivity at 6 weeks (time frame: from inclusion at 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in